New Australian collaboration to build gene and cell therapy production

July 15, 2025 Latest News Australian Biotech

This is a preview of subscriber content

Subscribe now to continue reading.

Viral Vector Manufacturing Facility and Cell Therapies have signed an MoU to explore strategic collaboration opportunities aimed at strengthening the onshore development and manufacture of Advanced Therapy Medicinal Products. …

Subscribe now to continue reading.

Latest Video

AstraZeneca confirms pricing the issue, and acts to create a patient access program
June 16, 2026 - Latest News
When good policy becomes self defeating, Australia must at least have a discussion about the obvious solution
June 16, 2026 - Latest News
Novartis names interim leader for Australia and NZ after Country President departs
June 17, 2026 - Latest News
These outcomes are mostly about the choices Australia is making
June 17, 2026 - Latest News
Paradigm reaches global milestone as Phase 3 osteoarthritis trial completes enrolment
June 15, 2026 - Australian Biotech

New Australian collaboration to build gene and cell therapy production

This is a preview of subscriber content

Latest Video

Most Read

AstraZeneca confirms pricing the issue, and acts to create a patient access program

When good policy becomes self defeating, Australia must at least have a discussion about the obvious solution

Novartis names interim leader for Australia and NZ after Country President departs

These outcomes are mostly about the choices Australia is making

Paradigm reaches global milestone as Phase 3 osteoarthritis trial completes enrolment

New Stories

Australians want more from healthcare as convenience, prevention and fragmentation reshape care

Life sciences leaders brace for class action wave as dispute risks multiply

Is China's international benchmarking a bigger short-term risk to medicines access?

Neurizon secures GMP supply of monepantel to strengthen NUZ 001 commercial readiness

Percheron completes HMBD-002 drug substance manufacture

Racura completes significant fund raise to advance three clinical trials

Novartis names interim leader for Australia and NZ after Country President departs

Sign In

New Australian collaboration to build gene and cell therapy production

This is a preview of subscriber content

Latest Video

Most Read

AstraZeneca confirms pricing the issue, and acts to create a patient access program

When good policy becomes self defeating, Australia must at least have a discussion about the obvious solution

Novartis names interim leader for Australia and NZ after Country President departs

These outcomes are mostly about the choices Australia is making

Paradigm reaches global milestone as Phase 3 osteoarthritis trial completes enrolment

Follow Us

New Stories

Australians want more from healthcare as convenience, prevention and fragmentation reshape care

Life sciences leaders brace for class action wave as dispute risks multiply

Is China's international benchmarking a bigger short-term risk to medicines access?

Neurizon secures GMP supply of monepantel to strengthen NUZ 001 commercial readiness

Percheron completes HMBD-002 drug substance manufacture

Racura completes significant fund raise to advance three clinical trials

Novartis names interim leader for Australia and NZ after Country President departs